Historical Background
Lipid modification is one of the most common posttranslational modifications in eukaryotic cells that take place either at or near the amino terminus or the carboxy terminus of the proteins (Resh 2013). This process is sequence specific and classified as myristoylation, palmitoylation, prenylation, and glycosylphosphatidylinositol according to the identity of the attached lipid. The structural changes resulting from these modifications have effects on the stability, cellular location, and biological activity of the proteins (Resh 2013). These processes are becoming increasingly important for the study of cancer, as several key oncoproteins require this type of “posttranslational maturation” for their biological activity and for their ability to transform cells. Among these lipid modifications, protein myristoylation is known to be very important which refers to the covalent...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clegg RA, Gordge PC, Miller WR. Expression of enzymes of covalent protein modification during regulated and dysregulated proliferation of mammary epithelial cells: PKA, PKC and NMT. Adv Enzym Regul. 1999;39:175–203.
Das U, Kumar S, Dimmock JR, Sharma RK. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents. Curr Cancer Drug Targets. 2012;12:667–92.
Ducker CE, Upson JJ, French KJ, Smith CD. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. Mol Cancer Res. 2005;3:463–76.
Giang DK, Cravatt BF. A second mammalian N-myristoyltransferase. J Biol Chem. 1998;273:6595–8.
King MJ, Sharma RK. Demonstration of multiple forms of bovine brain myristoyl CoA:protein N-myristoyl transferase. Mol Cell Biochem. 1992;113:77–81.
Kumar S, Sharma RK. N-terminal region of the catalytic domain of human N-myristoyltransferase 1 acts as an inhibitory module. PLoS One. 2015;10:e0127661.
Lu Y, Selvakumar P, Ali K, Shrivastav A, Bajaj G, Resch L, Griebel R, Fourney D, Meguro K, Sharma RK. Expression of N-myristoyltransferase in human brain tumors. Neurochem Res. 2005;30:9–13.
Magnuson BA, Raju RV, Moyana TN, Sharma RK. Increased N-myristoyltransferase activity observed in rat and human colonic tumors. J Natl Cancer Inst. 1995;87:1630–5.
Rajala RV, Datla RS, Moyana TN, Kakkar R, Carlsen SA, Sharma RK. N-myristoyltransferase. Mol Cell Biochem. 2000a;204:135–55.
Rajala RV, Kakkar R, Kanthan R, Radhi JM, Wang X, Wang R, Datla RS, Sharma RK. Altered expression and localization of N-myristoyltransferase in experimentally induced rat model of ischemia-reperfusion. J Cell Biochem. 2002;86:509–19.
Rajala RV, Radhi JM, Kakkar R, Datla RS, Sharma RK. Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer. 2000b;88:1992–9.
Raju RV, Moyana TN, Sharma RK. N-Myristoyltransferase overexpression in human colorectal adenocarcinomas. Exp Cell Res. 1997;235:145–54.
Resh MD. Covalent lipid modifications of proteins. Curr Biol. 2013;23:R431–5.
Resh MD. Targeting protein lipidation in disease. Trends Mol Med. 2012;18:206–14.
Selvakumar P, Lakshmikuttyamma A, Shrivastav A, Das SB, Dimmock JR, Sharma RK. Potential role of N-myristoyltransferase in cancer. Prog Lipid Res. 2007;46:1–36.
Selvakumar P, Smith-Windsor E, Bonham K, Sharma RK. N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system. FEBS Lett. 2006;580:2021–6.
Shoji S, Kurosawa T, Inoue H, Funakoshi T, Kubota Y. Human cellular src gene product: identification of the myristoylated pp60c-src and blockage of its myristoyl acylation with N-fatty acyl compounds resulted in the suppression of colony formation. Biochem Biophys Res Commun. 1990;173:894–901.
Shrivastav A, Sharma AR, Bajaj G, Charavaryamath C, Ezzat W, Spafford P, Gore-Hickman R, Singh B, Copete MA, Sharma RK. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma. Oncol Rep. 2007a;18:93–7.
Shrivastav A, Varma S, Saxena A, DeCoteau J, Sharma RK. N-myristoyltransferase: a potential novel diagnostic marker for colon cancer. J Transl Med. 2007b;5:58.
Shrivastav A, Varma S, Senger A, Khandelwal RL, Carlsen S, Sharma RK. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells. J Pathol. 2009;218:391–8.
Thinon E, Morales-Sanfrutos J, Mann DJ, Tat EW. N-myristoyltransferase inhibition induces ER-stress, cell cycle arrest, and apoptosis in cancer cells. ACS Chem Biol. 2016. doi:10.1021/acschembio. 6b00371.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Das, U. et al. (2018). NMT (N-Myristoyltransferase). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_538
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_538
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences